Lantern Pharma Files 2024 Annual Report Amendment

Ticker: LTRN · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1763950

Lantern Pharma Inc. 10-K/A Filing Summary
FieldDetail
CompanyLantern Pharma Inc. (LTRN)
Form Type10-K/A
Filed DateApr 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: amendment, annual-report, sec-filing

Related Tickers: LTRN

TL;DR

Lantern Pharma filed its amended 2024 10-K. Check for updates.

AI Summary

Lantern Pharma Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 30, 2025, provides updated information for the period. The company is incorporated in Delaware and headquartered in Dallas, Texas.

Why It Matters

This amendment to the annual report provides updated financial and operational information for Lantern Pharma Inc. for the fiscal year 2024, which is crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — This filing is an amendment to an annual report and does not introduce new material risks.

Key Numbers

  • 2024 — Fiscal Year End (The annual report covers the fiscal year ending December 31, 2024.)
  • April 30, 2025 — Filing Date (This amendment was filed on April 30, 2025.)

Key Players & Entities

  • Lantern Pharma Inc. (company) — Registrant
  • 2024 (date) — Fiscal year end
  • April 30, 2025 (date) — Filing date
  • Dallas, Texas (location) — Principal Executive Offices

FAQ

What is the purpose of this 10-K/A filing?

This filing is Amendment No. 1 to the Annual Report (Form 10-K) for the fiscal year ended December 31, 2024, indicating updates or corrections to the original filing.

When was the original 10-K filed?

The filing date for this amendment is April 30, 2025, and it pertains to the fiscal year ended December 31, 2024. The original filing date is not explicitly stated but implied to be prior to this amendment.

What is Lantern Pharma Inc.'s principal executive office address?

Lantern Pharma Inc.'s principal executive offices are located at 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201.

What is Lantern Pharma Inc.'s IRS Employer Identification Number?

Lantern Pharma Inc.'s IRS Employer Identification Number is 46-3973463.

In which state is Lantern Pharma Inc. incorporated?

Lantern Pharma Inc. is incorporated in Delaware.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Lantern Pharma Inc. (LTRN).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.